Concord Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Buy
+1,770
New +$207K 0.03% 210
2026
Q1
Sell
-1,360
Closed -$143K 571
2025
Q4
$143K Sell
1,360
-82
-6% -$7.7K 0.02% 219
2025
Q3
$121K Sell
1,442
-614
-30% -$50.6K 0.02% 237
2025
Q2
$163K Buy
2,056
+527
+34% +$41.9K 0.02% 219
2025
Q1
$137K Sell
1,529
-21,280
-93% -$1.99M 0.02% 216
2024
Q4
$2.27M Sell
22,809
-21,488
-49% -$2.22M 0.37% 66
2024
Q3
$5.03M Buy
44,297
+9,991
+29% +$1.19M 0.84% 28
2024
Q2
$4.25M Buy
34,306
+2,424
+8% +$312K 0.75% 34
2024
Q1
$4.21M Buy
31,882
+3,292
+12% +$406K 0.76% 33
2023
Q4
$3.12M Buy
28,590
+4,432
+18% +$460K 0.62% 39
2023
Q3
$2.49M Buy
24,158
+3,051
+14% +$329K 0.53% 36
2023
Q2
$2.44M Buy
21,107
+8,068
+62% +$916K 0.52% 38
2023
Q1
$1.39M Buy
13,039
+5,013
+62% +$541K 0.39% 38
2022
Q4
$890K Sell
8,026
-2,684
-25% -$274K 0.27% 51
2022
Q3
$922K Sell
10,710
-192
-2% -$17.1K 0.29% 51
2022
Q2
$994K Buy
10,902
+902
+9% +$80K 0.27% 50
2022
Q1
$820K Buy
10,000
+841
+9% +$66.3K 0.21% 65
2021
Q4
$702K Buy
9,159
+5,682
+163% +$453K 0.17% 75
2021
Q3
$261K Sell
3,477
-3,279
-49% -$249K 0.11% 72
2021
Q2
$525K Buy
6,756
+935
+16% +$69.5K 0.15% 64
2021
Q1
$428K Buy
5,821
+3,892
+202% +$287K 0.14% 72
2020
Q4
$151K Buy
+1,929
New +$148K 0.12% 92

Other funds holding MRK

Concord Wealth Partners's MRK Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Merck (MRK) in Q2 2026: 1,770 shares worth $227K. The stake represents 0.03% of the portfolio and ranks #210 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in MRK as recently as Q4 2025.

Concord Wealth Partners first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.03M in Q3 2024. 1,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Concord Wealth Partners held 1,770 shares of Merck worth $227K as of Q2 2026.
  • Merck was a new Concord Wealth Partners position in Q2 2026.
  • Merck made up 0.03% of Concord Wealth Partners's portfolio in Q2 2026, its #210 holding.
  • Concord Wealth Partners first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • Concord Wealth Partners's Merck position peaked at $5.03M in Q3 2024.
  • 1,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.